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Abstract
Because little is known about the role of corticotropin-releasing factor (CRF) agonists in reg-
ulating responses in pancreatitis, we evaluated the effects of urocortin 2 (UCN2) and stres-
sin1 in caerulein-induced acute pancreatitis (AP) model in rats. Male rats were pretreated
with UCN2 or stressin1 for 30 min followed by induction of AP with supraphysiologic doses
of caerulein. Serum amylase and lipase activity, pancreatic tissue necrosis, immune cell
infiltrate, nuclear factor (NF)-κB activity, trypsin levels, and intracellular Ca2+ ([Ca2+]i) were
ascertained. UCN2, but not stressin1 attenuated the severity of AP in rats. UCN2, but not
stressin1, reduced serum amylase and lipase activity, cell necrosis and inflammatory cell
infiltration in AP. NF-κB activity in pancreatic nuclear extracts increased in AP and UCN2
treatment reduced caerulein-induced increases in NF-κB activity by 42%. UCN2 treatment
prevented caerulein-induced degradation of IκB-α in the cytosolic fraction as well as
increased levels of p65 subunit of NF-κB in the cytosolic fraction. Pancreatic UCN2 levels
decreased in AP compared with saline. UCN2 evoked [Ca2+]i responses in primary acinar
cells and abolished caerulein-evoked [Ca2+]i responses at 0.1nM, and decreased by ~50%
at 1.0nM caerulein. UCN2 stimulation resulted in redistribution of a portion of F-actin from
the apical to the basolateral pole. UCN2 prevented the massive redistribution of F-actin
observed with supraphysiologic doses of caerulein. UCN2, but not stressin1 attenuated
severity of an experimental pancreatitis model. The protective effects of UCN2, including
anti-inflammatory and anti-necrotic effects involve activation of the CRF2 receptor, [Ca2+]i
signaling, and inhibition of NF-κB activity.
Introduction
The urocortins (UCN1-3) are members of the corticotropin-releasing factor (CRF) family of
neuropeptides [1]. CRF was originally isolated and characterized from the ovine hypothalamus
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[2] and is a potent stimulator of the secretion of ACTH and β-endorphins [3]. Urocortins are
mammalian homologs of Urotensins that were initially discovered in the urophysis gland of
the fish [4, 5]. UCNs along with CRF regulate the neuroendocrine responses to stress. UCNs
play an important role in regulation of diverse processes such as vascular tone [6–8], cardiac
function [9], visceral pain [10], immune cell activation, and gastrointestinal functions [11–16].
The urocortins exert their effects via two known receptors, CRF1 and CRF2 [17]. UCN1 binds
with similar affinity to both receptors, whereas UCN2 and UCN3 bind exclusively to CRF2
[18]. Localization of these ligands and receptors has been ascertained in the central nervous
system as well as in the peripheral tissues [11, 15, 19–22].
CRF-like immunoreactivity has been described in the endocrine pancreas of several classes
of vertebrates that include fish, amphibians, birds, rodents, non-human primates, and humans
[3]. In primates, CRF-containing endocrine cells are scattered within the pancreatic islets,
whereas in rodents, they are located at the periphery of the islets. CRF-like immunoreactivity
was also found to be interspersed between exocrine acinar cells in all species [3]. We have pre-
viously shown that CRF is secreted by cultured rat AR42J acinar cells and stimulation of
AR42J cells with caerulein results in ~2-fold induction in CRF and de novo induction of UCN1
mRNA levels [21]. UCN3 is also present in the islets and thought to be a differentiation marker
for β-cells [23]. Both CRF1 and CRF2 receptors are present in the human and rodent pancreatic
islets [23] and CRF2 mRNA is reported in pancreatic acinar cells [21].
Caerulein-induced pancreatitis is one of the best-characterized experimental models that
involves administration of high (supraphysiologic) doses of caerulein, a cholecystokinin ana-
log. Physiologic doses used cause maximal pancreatic secretion of amylase and lipase [24, 25].
However, supraphysiologic concentrations result in inhibition of pancreatic secretion, eleva-
tion of serum enzymes, edema formation, and infiltration of inflammatory cells into the pan-
creas, and ultimately death of acinar cells [26–28].
In human acinar cells [29], and in rodents, exposure to secretagogues [21, 30], nutrients
[31, 32] and radiocontrast [33] agents has been known to induce AP through mechanisms
involving intracellular Ca2+ signaling, trypsinogen activation, and endoplasmic reticulum (ER)
stress. Particularly, NF-κB activation plays a key role in regulating the expression of genes
involved in inflammation, cell injury, and cell death; and its role in caerulein-induced pancrea-
titis has been shown and characterized [34].
In male rats, UCN1, a ligand for both CRF1 and CRF2 receptors has been shown to increase
pancreatic secretory volume and protein secretion as well as to potentiate cholecystokinin-
stimulated protein secretion [35]. We have previously shown that UCN1 was induced de novo
in exocrine pancreatic acinar cells in the murine model of caerulein-induced acute pancreatitis
[21]. CRF2 receptor mRNA expression was also increased during AP, whereas CRF1 receptor
mRNA expression was not detected in the acinar cells. UCN1 reduced histologic damage in
male, but not female mice. UCN1 also decreased serum amylase levels and reduced ubiquitina-
tion of damaged proteins as well as other ER stress responses in a sex-specific manner [21].
However, the role of UCN2 in pancreatitis, the ligand that exclusively binds and activates
CRF2 receptor, has not been characterized. Here, we report the immunomodulatory effects of
UCN2 in pancreas of male rats. We used Stressin1, a synthetic CRF1 receptor-specific agonist,
to determine the role of CRF1 in caerulein-induced model of acute pancreatitis.
Materials and methods
Reagents
Stressin1 and mouse (m)UCN2 were provided by Dr. Jean Rivier, The Salk Institute and The
Clayton Foundation Laboratories for Peptide Biology, La Jolla, CA 92037, USA. UCN2 was
Neuropeptide UCN2 ameliorates acute pancreatitis in rats
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also purchased from Sigma (St. Louis, MO) and from American Peptides (Sunnyvale, CA).
Caerulein was obtained Peninsula Laboratories (Belmont, CA). NF-κB p65 Transcription fac-
tor assay kit was obtained from Active Motif (Carlsbad, CA). NF-κB, IκB-α, and GAPDH anti-
bodies were obtained from Cell Signaling (Beverly, MA). Ionomycin was purchased from
Molecular Probes (Fisher Scientific, CA) and Alexa Fluor 555 Phalloidin was purchased from
Cell Signaling Technology (Danvers, MA).
Animals and animal care guidelines
Male Sprague-Dawley rats (120–150 g) were used in all experiments. The animals were kept in
a temperature-(23 ± 2˚C) and humidity- (55 ± 5%) controlled room with a 12-hour light/dark
cycle. The animals were provided ad libitum standard rat chow and tap water. The Institu-
tional Animal Care and Use Committees of the Veterans Affairs Greater Los Angeles Health
Care System, Los Angeles and the University of California, San Francisco approved animal
care and all procedures, in accordance with the National Institutes of Health guidelines.
Experimental pancreatitis model
Rats were pre-treated with intraperitoneal (IP) injection of CRF1 receptor-specific agonist,
stressin1, or CRF2 receptor-specific agonist, UCN2, at doses of 10μg/kg body weight. Rats in
control group were injected with saline (vehicle). After 30 min, the pre-treated rats received 4
IP injections of caerulein (CR, 20 μg/kg body weight) at 1-hour intervals. Control rats contin-
ued to receive saline injections. The rats were euthanized 1 hour after the 4th IP injection of
caerulein or saline. Blood was collected in heparinized tubes for serum amylase and lipase
determinations. The pancreata were removed, rinsed in ice-cold PBS, and a portion of the tis-
sue was snap frozen in liquid nitrogen and stored at -80˚C. A part of the tissue was fixed in
10% paraformaldehyde and paraffin-embedded for histopathological examination.
Preparation of nuclear extracts and NF-κB DNA binding activity
measurement
Nuclear protein extracts were prepared from pancreatic tissue pre-treated saline or mUCN2
for 30 min followed by 1 IP injection of caerulein. Rats were euthanized 30 min later and pan-
creata were collected. Pancreatic nuclear extracts were prepared using the Active Motif
Nuclear Extract Kit (Carlsbad, CA) as per manufacturer’s instructions. NF-κB DNA binding
activities in the nuclear protein extracts were measured with ELISA method using Active
Motif NF-κB p65 Transcription factor assay kit (Carlsbad, CA) as per the manufacturer’s
instructions.
NF-κB and IκB western blotting
Western blot analysis on cytosolic fraction was performed for NF-κB and IκB-α levels as
described previously [36]. Briefly, equal amounts of protein lysates were separated on
SDS-PAGE and transferred to nitrocellulose membranes. The membranes were blocked with
5% nonfat dried milk in Tris-buffered saline, pH 7.2 for 2 hours at room temperature followed
by overnight incubated with specific primary antibodies NF-κB or IκB-α (1:1000) in Tris-buff-
ered saline containing 3% nonfat dried milk at 4˚C. After washes, the membranes were incu-
bated with secondary antibodies conjugated with horseradish peroxidase (1:5000) for 1h at
room temperature. Blots were developed using the enhanced chemiluminescence detection kit
(Pierce). The bots were subsequently stripped and reprobed with GAPDH (1:1000), which was
used as a loading control.
Neuropeptide UCN2 ameliorates acute pancreatitis in rats
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Enzymatic assays
Serum amylase and lipase levels were determined by using a Hitachi 707 analyzer (Antech
Diagnostics, Irvine, CA). Active trypsin in pancreatic tissue was measured using Boc-Gln-Ala-
Arg-AMC as a substrate by a fluorogenic assay as described previously [37, 38].
Histological measurements
Pancreatic tissue was fixed immediately in 10% buffered formaldehyde. Tissue was then
embedded in paraffin and 5μm sections were cut and stained with hematoxylin and eosin
(H&E). Sections were examined by light microscopy for assessment of parenchymal structure,
inflammation, and acinar cell necrosis. Images were acquired using a light microscope (40X
objective), and images were captured using all exposures manually set at equal times with a
Nikon Eclipse E600 microscope equipped with a digital camera using the SPOT imaging soft-
ware (Diagnostic Instruments, Sterling Heights, MI).
Quantification of necrosis was performed on H&E stained pancreatic sections. Images
from multiple, non-overlapping sections were captured under a high-power field (x400-mag-
nification, 6 to 10 random fields per section). Cells with swollen cytoplasm, loss of plasma
membrane integrity, and leakage of organelles into interstitium were considered necrotic. A
total of at least 2000 acinar cells were counted on tissue sections from each animal per condi-
tion (n = 3-5/group). Inflammatory cell infiltration was also quantified from H&E stained pan-
creatic sections from 3 rats per group and expressed as the number of inflammatory cells or
vacuoles per 100 acinar cells.
ELISA for UCN2
Rat pancreatic acinar cells were prepared by injecting the pancreas with 1mL of 200 units/mL
collagenase and digesting for 25 min at 37˚C with agitation. Small clusters of cells were
released by agitation and cells were washed 3x by centrifugation in extracellular Ca2+ buffer
containing 140 mM NaCl, 4.7 mM KCl, 1.13 mM MgCl2, 1mM CaCl2, 10mM D-glucose, 10
mM HEPES (pH 7.2), and 0.5% BSA. Cluster of acinar cells were treated as follows: a)
untreated, b) 0.1nM caerulein (CR), c) 1.0nM CR, d) 100nM UCN2 for 30 minutes at 37˚C,
pre-treated for 30 min with 100nM UCN2 followed by 30 min treatment with e) 0.1nM CR, or
f) 1.0nM CR. Cells were washed in 1x PBS. Protein lysates from primary acinar cells and pan-
creatic tissues (~150mg) were prepared by homogenizing cells/tissues in 1X PBS containing
protease and phosphatase inhibitors (Sigma, St. Louis, MO). The lysate was spun at 10,000
rpm for 15 minutes at 4˚C and supernatant (cytoplasmic proteins) was collected and stored at
-80KC until use. Total protein was assessed using the DC protein assay (Bio Rad, Hercules,
CA). Two concentrations of total protein (30 and 60μg) were used in ELISA assay.
UCN2 ELISA was performed as per manufacturer’s specifications (Aviva Systems Biology,
San Diego, CA). Briefly, 30 and 60μg of total protein in 100μL of standard dilution buffer were
added into wells of the anti-UCN2 microplate, covered, and incubated at 37˚C for 60 minutes.
The liquid was discarded by flicking and incubated with 100μL of biotinylated UCN2 detector
antibody for 60 minutes at 37˚C. The plate was washed 3x with 300μL of 1x wash buffer for 1
minute each. Subsequently, 100μL of 1x Avidin-HRP conjugate was added to the wells and
incubated for 30 minutes at 37˚C followed by 5x washes. TMB substrate (90μL) was added to
each well and the plate was incubated in the dark for approximately 12 minutes to develop the
reaction. Stop solution (50μL) was added to each well to terminate the reaction. Standard
range used was from 0-50ng/mL of UCN2. Absorbance was read at 450nm and wavelength
correction was set to 570nm.
Neuropeptide UCN2 ameliorates acute pancreatitis in rats
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Phalloidin staining and confocal microscopy
Rat pancreatic acinar cells were prepared as described above. Cluster of acinar cells were
treated as follows: a) untreated, b) 1.0nM caerulein (CR), c) 100nM UCN2 for 30 minutes at
37˚C, pre-treated for 30 min with 100nM UCN2 followed by 30 min treatment with d) 1.0nM
CR. Cells were washed with 1x PBS, embedded in OCT. Sections (20μm) were air dried,
washed 3x with 1x PBS, blocked with 1x PBS containing 5% normal horse serum for 30 min at
room temperature. Cells were stained with Alex Fluor 555 phalloidin (330nM) as per manufac-
turer’s specifications. Sections were observed with a Zeiss laser scanning confocal microscope
(LSM Meta 510; Carl Zeiss, Thornwood, NY) using an x63 oil objective and images were cap-
tured at equal settings.
Intracellular Ca2+ [Ca2+]i measurement of primary acinar cells
Pancreas was obtained from adult C57/BL6 mouse and primary acinar cells were prepared by
injecting the pancreas with 1mL of 200 units/mL collagenase and digesting for 25 min at 37˚C
with agitation. Small clusters of cells were released by agitation and cells were washed 3x by cen-
trifugation in extracellular buffer containing 140 mM NaCl, 4.7 mM KCl, 1.13 mM MgCl2, 1mM
CaCl2, 10mM D-glucose, 10 mM HEPES (pH 7.2), and 0.5% BSA. Cells were loaded with Fura-
2AM for 30 min at 37˚C in buffer containing 1mM CaCl2. Cells were washed 3x and ~2,000
acini were seeded on poly D lysine-coated 96-well plates. Cells were sequentially stimulated with
UCN2 (10nM or 100nM), caerulein (0.1nM or 1nM) in FlexStation 2 microplate reader (Molec-
ular Devices) using dual wavelengths. Cells were finally stimulated with 1 μM ionomycin 90 sec-
onds after last agonist stimulation, as indicated in the example Ca2+ traces to confirm cell
viability (n = 6-8/condition). When Fura-2AM-loaded cells are excited at 340nm, emission value
increases with increasing Ca2+ concentrations. In contrast, when loaded cells are excited at
380nm, Fura-2 signal decreases with increasing Ca2+ concentrations. The ratio of 340nm:380nm
emissions is reflective of Ca2+ concentrations [39]. Agonist-induced peak Ca2+ responses were
normalized to peak ionomycin-induced responses [40] to obtain changes in Ca2+ concentra-
tions. Agonist stimulations included UCN2 at 10-100nM and caerulein at 0.1–1.0nM.
Statistical analysis
One-way ANOVA followed by Tukey’s multiple comparison was used to analyze data using
Prism v8.02 software (GraphPad Software Inc., La Jolla, CA). A p value of p<0.05 was consid-
ered statistically significant. Data are shown as mean ± standard error of mean (SEM).
Results
UCN2 decreased serum amylase and lipase activity in caerulein-induced
pancreatitis
Serum amylase and lipase activities were increased, as expected, following induction of AP
with caerulein (Fig 1A and 1B). Pre-treatment of rats with the CRF2 receptor agonist, UCN2,
significantly reduced caerulein-induced serum amylase and lipase activity by 43% and 48%,
respectively. Unlike UCN2, pre-treatment with the CRF1 receptor agonist, stressin1, did not
change caerulein-induced amylase and lipase activities (Fig 1A and 1B).
UCN2 decreased acinar cell necrosis
Histological analysis revealed that UCN2-treated pancreatic tissue was well preserved and con-
siderably less necrotic than caerulein-treated tissue (Fig 2A). UCN2 treatment decreased the
Neuropeptide UCN2 ameliorates acute pancreatitis in rats
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numbers of necrotic acinar cells by nearly 7-fold compared with caerulein and stressin1 treat-
ments (Fig 2B). Stressin1 treatment had no effect on caerulein-induced cell necrosis (Fig 2B).
UCN2 decreased infiltrated inflammatory cell numbers
Infiltration of polymorphonuclear cells is seen during induction of acute pancreatitis. As
expected, caerulein treatment markedly increased numbers of infiltrated immune cells in
the pancreas, whereas UCN2 treatment decreased immune cell infiltration by nearly 7-fold
Fig 1. Serum amylase and lipase activity. UCN2 reduced serum (A) amylase activity by 43% and (B) lipase activity by
48% compared with caerulein treatment. Data are shown as mean ± SD (n = 3), one-way ANOVA and Tukey’s
multiple comparisons. CR: caerulein. Amylase: ���: p<0.0001 vs. saline; #: p = 0.0038 saline vs. UCN2 + CR; �:
p = 0.0145 Stressin1 +CR vs. UCN2 + CR. For Lipase: ���: p = 0.0001 vs. saline; #: p = 0.0107 saline vs. UCN2 + CR; �:
p = 0.019 Stressin1 +CR vs. UCN2 + CR.
https://doi.org/10.1371/journal.pone.0217065.g001
Neuropeptide UCN2 ameliorates acute pancreatitis in rats
PLOS ONE | https://doi.org/10.1371/journal.pone.0217065 May 17, 2019 6 / 15
(Fig 3). Stressin1 did not alter the numbers of immune cells (Fig 3). These results indicate that
activation of the CRF2 receptors, but not the CRF1 receptors, attenuates pancreatic responses.
UCN2 levels decreased after acute pancreatitis induction
Since UCN2 administration had anti-inflammatory actions, we next ascertained if caerulein
altered UCN2 levels in the pancreatic lysates as well primary acinar cells using ELISA. Com-
pared with saline-treated rats, caerulein treatment decreased UCN2 in the pancreas. Pre-treat-
ment with UCN2 resulted in further depression of endogenous UCN2 levels in the pancreas
even in the face of caerulein treatment (Fig 4). In contrast, treatment of primary acinar cells
with caerulein or UCN2, did not change UCN2 levels (Fig 4), suggesting that paracrine input
is needed for this change to occur.
UCN2 inhibited activation of NF-κB
Translocation of NF-κB subunits from the cytoplasmic compartment to the nucleus results in
transcriptional activation of a number of pro-inflammatory genes in pancreatic acini [34].
Next, we ascertained if UCN2 mediated its anti-inflammatory effect in AP via the NF-κB sig-
naling pathway. As expected, caerulein treatment resulted in increased NF-κB activity in the
nuclear fraction, whereas UCN2 treatment decreased NF-κB by nearly 42% (Fig 5A).
UCN2 modulated trypsin activity
Trypsin activity and levels are increased in pancreatitis. As expected, caerulein treatment
resulted in a ~6.6-fold increase in trypsin activity in pancreatic lysates, whereas pre-treatment
with UCN2 resulted in ~5.6-fold increase in trypsin activity (Fig 5C). UCN2 treatment caused
Fig 2. Histopathology and effect of UCN2 on cell necrosis. (A) Representative micrographs showing H&E staining of pancreatic
tissue sections. Necrotic cells are shown within yellow circles and arrows point to inflammatory cell infiltrates. Scale bar: 20μm. (B)
Necrosis measurement: Necrosis was assessed on H&E stained pancreatic tissue sections using the following criteria- swollen cytoplasm,
loss of plasma membrane integrity, and organelle leakage into interstitium. Data are shown as mean ± SEM (n = 3) for each condition.
One-way ANOVA and Tukey’s multiple comparisons. CR: caerulein. ��: p = 0.0059 Saline vs. CR; #: p = 0.0030 Saline vs. Stressin1 +CR.
https://doi.org/10.1371/journal.pone.0217065.g002
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a modest (15%), but significant decrease in trypsin activity, thereby suggesting that UCN2-me-
diated mechanisms are largely independent of trypsinogen activation, at least in the acute
phase.
Fig 3. UCN2 reduced neutrophil infiltration. Number of inflammatory cell infiltration (neutrophils) was counted on
H&E stained pancreatic tissue sections and expressed as percentage of total acinar cells. Data are shown as
mean ± SEM (n = 3) for each condition. One-way ANOVA and Tukey’s multiple comparisons. CR: caerulein. �:
p = 0.0112 Saline vs. CR; ��: p = 0.0012 Saline vs. Stressin1 +CR.
https://doi.org/10.1371/journal.pone.0217065.g003
Fig 4. Loss of UCN2 expression in caerulein-induced pancreatitis. UCN2 levels decreased in pancreatic lysates from
UCN2 + caerulein-treated rats compared with saline-treated rats (p = 0.042), 1-way ANOVA, whereas UCN2 levels did
not change in primary acinar cells.
https://doi.org/10.1371/journal.pone.0217065.g004
Neuropeptide UCN2 ameliorates acute pancreatitis in rats
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UCN2 modulated intracellular Ca2+ [Ca2+]i levels in primary acinar cells
One mechanism by which caerulein mediates its detrimental effects on secretion are by
increasing [Ca2+]i to levels that if remained unchecked can lead to organelle damage and cell
death via mechanisms that involve mitochondrial depolarization. In primary acinar cells,
UCN2 treatment evoked [Ca2+]i responses at concentrations of 10nM and 100nM (Fig 6A–
6C). Interestingly, 100nM UCN2 prevented increases in [Ca2+]i at 0.1nM caerulein and
reduced responses by 50% at 1.0nM caerulein, a dose that results in prolonged and sustained
increases in [Ca2+]i and pancreatitis responses (Fig 6B and 6C). These results indicate that the
actions of UCN2 and caerulein differ with respect to [Ca2+]i responses, although the reasons
for these differences are not revealed here.
UCN2 treatment prevented caerulein-induced redistribution of F-actin
filaments
Supraphysiologic doses of caerulein are known to cause redistribution of F-actin from the api-
cal to the basolateral pole [41]. We next stimulated primary rat acinar cells with caerulein or
UCN2. In unstimulated acinar cells, F-actin was mostly apical in location (Fig 7A), whereas
stimulation with supraphysiologic doses of caerulein (1.0nM) resulted in marked redistribu-
tion of F-actin from the apical to the basolateral membranes (Fig 7B, arrows). Our results here
Fig 5. Effect of UCN2 on NF-κB and trypsin activity and IκB degradation. Rats were pre-treated with saline or UCN2 for 30 min
followed by treatment with caerulein for 1 hour. (A) NF-κB DNA binding activities were measured in the pancreatic nuclear extracts
using ELISA. UCN2 treatment decreased NF-κB by nearly 42% in the nuclear extracts. (B) Western blot analysis showed decreased IκB-
α and NF-κB levels in pancreatic tissue cytosolic extract after caerulein treatment compared with saline controls, suggesting either
increased degradation IκB-α or increased translocation of NF-κB from the cytosol to the nucleus. UCN2 treatment prevented caerulein-
induced changes in IκB-α degradation and NF-κB nuclear translocation. GAPDH, a housekeeping protein was used as a loading
control (n = 3/condition). (C) Trypsin activity was increased after caerulein treatment and UCN2 treatment had a modest (15%) effect
on trypsin activity. Values are means ± SEM (n = 5). One-way ANOVA and Tukey’s multiple comparisons. CR: caerulein.
https://doi.org/10.1371/journal.pone.0217065.g005
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Fig 6. UCN2 evokes Ca2+ transients in primary acinar cells. Primary acinar cells were loaded with Fura2AM and stimulated with
secretagogues as shown. (A) Peak [Ca2+]i increased in response to stimulations with 0.1nM caerulein (CR), 10nM, and 100nM
UCN2. Ca2+ peaks were normalized to ionomycin responses. Stimulation with UCN2 showed dose-dependent increases in Ca2+
responses. Lower panel shows a cluster of Fura2AM-loaded acini. (B) Primary acinar cells were first stimulated with 10nM or
100nM of UCN2 followed by stimulation with 0.1nM or 1.0nM CR as shown. 100nM of UCN2 completely abrogated CR to induce
Neuropeptide UCN2 ameliorates acute pancreatitis in rats
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show that stimulation with 100nM UCN2 caused partial redistribution of F-actin from the api-
cal to basolateral area of the cell (Fig 7C, arrows) and prevented the massive redistribution
caused by caerulein (Fig 7D).
Discussion
Cellular stress responses are key for maintaining normal cellular function and homeostasis.
Components of the CRF family of neuropeptide hormones that include UCNs have been
Ca2+ peak responses at 0.1nM and reduced Ca2+ peak responses by 50% at 1.0nM, whereas 10nM UCN2 was not effective at
modulating CR-induced Ca2+ responses. (C) Representative traces of Ca2+ peaks generated after stimulation with CR, UCN2, and
ionomycin. N = 6-8/condition. One-way ANOVA and Tukey’s multiple comparisons.
https://doi.org/10.1371/journal.pone.0217065.g006
Fig 7. UCN2 prevents F-actin redistribution and over secretion in the face of caerulein. Pancreatic primary acinar cells
were stained with Alexa Fluro 555 phalloidin to visualize F-actin bundles. (A) in unstimulated acini, F-actin was primarily
seen at the apical poles. (B) stimulation with 1.0nM caerulein or (C) 100nM UCN2 for 30 minutes resulted in robust
redistribution of F-actin from the apical to the basolateral pole, along with presence of secretory granules near the
basolateral surface (arrows). (D) Pre-treatment with 100nM UCN2 followed by 1.0nM caerulein for 30 min restored apical
F-actin expression.
https://doi.org/10.1371/journal.pone.0217065.g007
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shown to modulate immune function, cellular signaling [11–16] as well as secretion [21].
Here, we show that UCN2 ameliorated caerulein-induced pancreatitis measured by reductions
in levels of serum amylase and lipase; and tissue measurements of cell necrosis, immune cell
infiltration, as well as by inhibition of NF-κB activation. UCN2 treatment prevented caerulein-
induced degradation IκB-α as well as nuclear translocation of NF-κB. Finally, UCN2 was
found to be a secretagogue that evoked [Ca2+]i responses and well as redistributed F-actin in
acinar cells.
UCN2 is potent vasodilator and one possible mechanism by which it could influence pan-
creatic function is by increasing blood flow to the organ, which is known to be compromised
in pancreatitis [42]. UCN1, a closely related peptide and which interacts with both CRF1 and
CRF2 receptors has also been shown to reduce serum amylase and inflammation in caerulein-
induced pancreatitis model in mice [21]. Interestingly, stressin1, a CRF1 receptor agonist did
not have effects on caerulein-induced pancreatitis suggesting that the protective effects of both
UCN1 and UCN2 are likely mediated via CRF2 receptor. In contrast to UCN1 levels, which
have been shown to increase in caerulein-induced pancreatitis [21], in this study, UCN2 levels
decreased. Taken together, these data suggest that an interplay and balance between different
UCNs is needed to fine tune inflammatory responses in pancreatitis.
Cytokines and chemokines play an important role in mediating inflammation. Transloca-
tion of the NF-κB from the cytoplasm to the nucleus results in activation of multiple pro-
inflammatory genes and increases in circulating levels of cytokines in pancreatitis models [34].
Prevention of NF-κB translocation to the nucleus has a direct effect on TNF-α [43] and other
cytokines levels [34]. We found that treatment with UCN2 decreased nuclear NF-κB activity,
whereas stressin1 did not. Furthermore, while as expected, caerulein treatment resulted in deg-
radation of cytosolic IκB-α as well decreased expression of NF-κB, UCN2 treatment prevented
caerulein-induced degradation of IκB-α, as well as nuclear translocation of NF-κB. These data
further suggests that UCN2 actions in the pancreas might be mediated by CRF2 receptor. In
agreement with this notion, CRF2 receptor knockout mice have more exacerbated histological
damage than wild-type controls [21].
Intra-pancreatic activation of trypsinogen is involved in pancreas injury and pancreatitis.
Increased pancreatic trypsin levels are seen in animal models of pancreatitis [44]. While caeru-
lein treatment increased trypsin activity in the pancreas in our studies, UCN2 treatment had a
modest effect on trypsin activity, suggesting that UCN2-mediated mechanisms are only partly
involved in trypsinogen pathways.
Secretion from the pancreatic acinar cells is tightly regulated by intracellular concentrations
of Ca2+ as well as redistribution of F-actin. However, sustained increases in [Ca2+]i that are a
predominant feature of caerulein-induced pancreatitis are detrimental, leading to organelle
damage, inhibited secretion, and can ultimately result in cell death [45]. We found that UCN2
also evokes [Ca2+]i responses in primary acinar cells as well as redistributes F-actin from the
apical to the basolateral surface. Interestingly, UCN2 treatment blocked caerulein-stimulated
Ca2+ responses in cells treated with more physiologic concentrations of caerulein. At high
doses of caerulein that cause pancreatitis like symptoms, UCN2 reduced caerulein-evoked
[Ca2+]i by 50% and also prevented the massive redistribution of F-actin. While UCN2 is
known to increase both cAMP and Ca2+ levels in other cell types [40], the mechanisms of these
effects of UCN2 on [Ca2+]i and F-actin redistribution, both alone and with caerulein in acinar
cells remain to be elucidated.
In conclusion, we show that UCN2 attenuated experimental pancreatitis; its protective
effects including anti-inflammatory and anti-necrotic effects are potentially due the effect of
UNC2 on activation of NF-κB pathway [46]. UCN2 also mediates its protective effects via F-
actin redistribution and modulation of intracellular [Ca2+]i levels.
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